4540 TSUMURA & CO.ツムラTSE Prime / Pharmaceuticals
0 posts
TSUMURA & CO. (4540) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
TSUMURA & CO. (4540) Stock Price History
TSUMURA & CO. closed at ¥3,973 on Nov 20, 2026, +4.2% over 1 month, +5.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥104,196 today (+4.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved +4.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥3,973 | −102 | −2.50% |
| Nov 19 (Thu) | ¥4,075 | +69 | +1.72% |
| Nov 18 (Wed) | ¥4,006 | +41 | +1.03% |
| Nov 17 (Tue) | ¥3,965 | −30 | −0.75% |
| Nov 16 (Mon) | ¥3,995 | +51 | +1.29% |
| Nov 13 (Fri) | ¥3,944 | +30 | +0.77% |
| Nov 12 (Thu) | ¥3,914 | +76 | +1.98% |
| Nov 11 (Wed) | ¥3,838 | −63 | −1.61% |
| Nov 10 (Tue) | ¥3,901 | +0 | +0.00% |
| Nov 9 (Mon) | ¥3,901 | +169 | +4.53% |
If you had invested ¥100,000 3 months ago, it would be worth ¥106,003 today (+6.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved +6.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥3,973 | −102 | −2.50% |
| Nov 19 (Thu) | ¥4,075 | +69 | +1.72% |
| Nov 18 (Wed) | ¥4,006 | +41 | +1.03% |
| Nov 17 (Tue) | ¥3,965 | −30 | −0.75% |
| Nov 16 (Mon) | ¥3,995 | +51 | +1.29% |
| Nov 13 (Fri) | ¥3,944 | +30 | +0.77% |
| Nov 12 (Thu) | ¥3,914 | +76 | +1.98% |
| Nov 11 (Wed) | ¥3,838 | −63 | −1.61% |
| Nov 10 (Tue) | ¥3,901 | +0 | +0.00% |
| Nov 9 (Mon) | ¥3,901 | +169 | +4.53% |
If you had invested ¥100,000 6 months ago, it would be worth ¥101,043 today (+1.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved +1.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥3,973 | +4.0% |
| Oct 2026 | ¥3,821 | +0.9% |
| Sep 2026 | ¥3,786 | +0.1% |
| Aug 2026 | ¥3,782 | −0.9% |
| Jul 2026 | ¥3,817 | +2.6% |
| Jun 2026 | ¥3,719 | −2.4% |
| May 2026 | ¥3,810 | +4.4% |
If you had invested ¥100,000 1 year ago, it would be worth ¥104,967 today (+5.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +5.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥3,973 | +4.0% |
| Oct 2026 | ¥3,821 | +0.9% |
| Sep 2026 | ¥3,786 | +0.1% |
| Aug 2026 | ¥3,782 | −0.9% |
| Jul 2026 | ¥3,817 | +2.6% |
| Jun 2026 | ¥3,719 | −2.4% |
| May 2026 | ¥3,810 | +4.4% |
| Apr 2026 | ¥3,651 | −2.5% |
| Mar 2026 | ¥3,746 | −10.6% |
| Feb 2026 | ¥4,190 | +2.6% |
| Jan 2026 | ¥4,083 | +0.1% |
| Dec 2025 | ¥4,077 | +4.3% |
| Nov 2025 | ¥3,909 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥144,211 today (+44.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +44.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,973 | −2.6% |
| 2025 | ¥4,077 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥117,025 today (+17.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +17.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,973 | −2.6% |
| 2025 | ¥4,077 | ― |
If you had invested ¥100,000 in Jan 2001, it would be worth ¥1,351,361 today (+1,251.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +334.1%, while this stock moved +1,251.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,973 | −2.6% |
| 2025 | ¥4,077 | −13.4% |
| 2024 | ¥4,708 | +77.2% |
| 2023 | ¥2,657 | −8.3% |
| 2022 | ¥2,898 | −11.5% |
| 2021 | ¥3,275 | +5.6% |
| 2020 | ¥3,100 | −3.4% |
| 2019 | ¥3,210 | +5.1% |
| 2018 | ¥3,055 | −18.4% |
| 2017 | ¥3,745 | +16.3% |
| 2016 | ¥3,220 | −4.5% |
| 2015 | ¥3,370 | +25.9% |
| 2014 | ¥2,677 | −4.0% |
| 2013 | ¥2,788 | +6.8% |
| 2012 | ¥2,610 | +15.0% |
| 2011 | ¥2,270 | −13.7% |
| 2010 | ¥2,629 | −12.4% |
| 2009 | ¥3,000 | −9.9% |
| 2008 | ¥3,330 | +51.0% |
| 2007 | ¥2,205 | −20.7% |
| 2006 | ¥2,780 | −14.7% |
| 2005 | ¥3,260 | +101.2% |
| 2004 | ¥1,620 | +52.1% |
| 2003 | ¥1,065 | −1.4% |
| 2002 | ¥1,080 | +137.4% |
| 2001 | ¥455 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2001). Please check the latest prices before trading.
TSUMURA & CO. (4540) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of TSUMURA & CO. (4540)
Business overview
The company runs a pharmaceutical business, making and selling prescription and over-the-counter drugs in Japan. Its subsidiary Yubari Tsumura grows, procures, sorts, processes and stores crude drugs used as raw materials. In China, subsidiaries in Shanghai and Tianjin make and sell Kampo extract powders, and other group companies procure and process crude drugs and make and sell prepared Chinese herbal pieces. It grows crude drugs in Laos and develops pharmaceuticals in the US.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 3.98% | No. 6 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 10.1x | Below the sector median of 16.5x (No. 9 from the lowest) |
| PBR | 0.87x | Below the sector median of 1.86x (No. 16 from the lowest) |
| ROE | 8.62% | No. 17 in the sector (highest first); median 4.17% |
| Market cap | ¥296.2 bn | No. 13 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥4,236 | 1/8 |
|---|---|---|
| 52-week low | ¥3,527 | 5/12 |
| Current position | 62.9% | Where the low is 0% and the high is 100% (close on 11/20: ¥3,973) |
| Year to date | -2.5% | No. 23 of 77 in the sector (best first) |
| 1 year | +5.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/09 11:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 11/09 11:302027年3月期 第2四半期(中間期)決算補足資料
- 10/28 17:002027年3月期第2四半期(中間期)および通期連結業績予想の修正に関するお知らせ
Filings from the past 12 months (3).
Shareholder benefits of TSUMURA & CO.
Details and disclosure history of TSUMURA & CO.'s shareholder benefits
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the TSUMURA & CO. board
More Japanese stocks in English
- TERUMO CORPORATION4543
- H.U. Group Holdings,Inc.4544
- KISSEI PHARMACEUTICAL CO.,LTD.4547
- SEIKAGAKU CORPORATION4548
- EIKEN CHEMICAL CO.,LTD.4549
- JCR Pharmaceuticals Co.,Ltd.4552
- TOWA PHARMACEUTICAL CO.,LTD.4553
- Fuji Pharma Co.,Ltd.4554
- CHUKYO IYAKUHIN CO.,LTD.4558
- ZERIA PHARMACEUTICAL CO.,LTD.4559
- Value Soft Holdings Corporation455A
- AnGes,Inc.4563